Combined therapy with SGLT2i and GLP-1ra improves cardiovascular prognosis in a population with diabetes and overweigh or obesity. A real-world clinical practice study

Back

ESC Professional Premium Access

Combined therapy with SGLT2i and GLP-1ra improves cardiovascular prognosis in a population with diabetes and overweigh or obesity. A real-world clinical practice study

Session: Diabetes and the heart (2)

Topic: Pharmacotherapy

Speaker: Doctor D. Garcia Vega (Santiago de Compostela, ES)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor David Garcia Vega

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)

0 follower

5 more presentations in this session

Sex differences in the clinical profile of individuals with prediabetes and type 2 diabetes mellitus in the general population - results from the Gutenberg Health Study

Speaker: Doctor V. Schmitt (Mainz, DE)

Time to act: the challenge of high incidence of diabetes and prediabetes in patients admitted with different cardiovascular diseases phenotypes

Speaker: Doctor V. Medovchshikov (Aktobe, KZ)

Modifications of short-term heart rate variability in metabolic syndrome: a systematic review and meta-analysis

Speaker: Mr J. Ortiz-Guzman (Valencia, ES)

Metabolic syndrome and long-term heart rate variability: a systematic review and meta-analysis

Speaker: Mr J. Ortiz-Guzman (Valencia, ES)

Effect of sodium-glucose co-transporter inhibitors on arterial stiffness in patients with type 2 diabetes mellitus

Speaker: Doctor J. Szigeti (Mohacs, HU)

Access the full session

Diabetes and the heart (2)

Speakers: Doctor D. Garcia Vega, Doctor V. Schmitt, Doctor V. Medovchshikov, Mr J. Ortiz-Guzman, Mr J. Ortiz-Guzman...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources